Medpace Reports Q3 2026 Financial Results and Updates Outlook

Medpace Holdings, Inc. reported Q3 2026 revenue of $716.0 million, exceeding the FactSet estimate of $714.5 million, and earnings per share (EPS) of $4.84, surpassing the consensus estimate of $4.44. The company updated its full-year 2026 guidance, now expecting revenue between $2.84 billion and $2.86 billion and an EPS range of $17.97 to $18.32, both of which are favorable compared to prior market expectations.